A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

Clinical trial NCT03693014 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03693014
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Cancer Melanoma Cancer Lung Cancer Bladder Cancer Renal Cancer Head/Neck Cancers

Start date: 2018-10-01
Primary completion: 2027-10-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.